Development and validation of an LC-MS/MS method for simultaneous quantification of hesperidin and hesperetin in rat plasma for pharmacokinetic studies

Jr Ting Lee, Li Heng Pao, Chang Da Hsieh, Pei Wei Huang, Oliver Yoa Pu Hu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A simple and sensitive method for the determination of hesperidin and hesperetin was necessary for a pharmacokinetic (PK) study in Wistar rats. Polarity-switching mode was utilized to acquire positive ion electrospray data for hesperidin and neohesperidin dihydrochalcone-d3, and negative ionization data for hesperetin and rac-hesperetin-d3. The analytes were investigated in the multiple reaction monitoring mode as the precursor/product ion pair of m/z 611.2 → 303.1 for hesperidin, m/z 616.3 → 308.3 for neohesperidin dihydrochalcone-d3, m/z 301.3 → 164.1 for hesperetin, and m/z 304.3 → 164.1 for rac-hesperetin-d3. Hesperidin and hesperetin in rat plasma were separated with solid-phase extraction using a HyperSep Retain PEP column and separated on a Hypersil GOLD Phenyl reversed-phase column using a gradient elution of 0.1% formic acid in water and acetonitrile. Hesperidin was validated over the concentration range of 1-1000 ng mL-1, and hesperetin was validated over the range of 0.2-100 ng mL-1, both with r > 0.999. The respective within- and between-run precisions were 2.06-9.54% and 2.11-7.76%, and the within- and between-run accuracies were -6.52% to 3.82% and -1.62% to 2.33%, respectively, for both analytes. Extraction recoveries of these analytes were >87%. The matrix effects were between 94.7% and 113.6%. All of the analytes were stable during the assay and storage in Wistar rat plasma. The lower limit of quantification of the active metabolite hesperetin is up to 200 pg mL-1, so complete plasma concentration-time profiles can be obtained by the LC-MS/MS method without the need for enzymatic hydrolysis of the serum sample.

Original languageEnglish
Pages (from-to)3329-3337
Number of pages9
JournalAnalytical Methods
Volume9
Issue number22
DOIs
Publication statusPublished - Jun 14 2017
Externally publishedYes

Fingerprint

Hesperidin
Pharmacokinetics
Rats
Plasmas
Enzymatic hydrolysis
Formic acid
Metabolites
Acetonitrile
formic acid
Ionization
Assays
Positive ions
Recovery
Monitoring
Ions
hesperetin
Water

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemical Engineering(all)
  • Engineering(all)

Cite this

Development and validation of an LC-MS/MS method for simultaneous quantification of hesperidin and hesperetin in rat plasma for pharmacokinetic studies. / Lee, Jr Ting; Pao, Li Heng; Hsieh, Chang Da; Huang, Pei Wei; Hu, Oliver Yoa Pu.

In: Analytical Methods, Vol. 9, No. 22, 14.06.2017, p. 3329-3337.

Research output: Contribution to journalArticle

Lee, Jr Ting ; Pao, Li Heng ; Hsieh, Chang Da ; Huang, Pei Wei ; Hu, Oliver Yoa Pu. / Development and validation of an LC-MS/MS method for simultaneous quantification of hesperidin and hesperetin in rat plasma for pharmacokinetic studies. In: Analytical Methods. 2017 ; Vol. 9, No. 22. pp. 3329-3337.
@article{a370ff4ed3f44af7aba8d7d24e0b3289,
title = "Development and validation of an LC-MS/MS method for simultaneous quantification of hesperidin and hesperetin in rat plasma for pharmacokinetic studies",
abstract = "A simple and sensitive method for the determination of hesperidin and hesperetin was necessary for a pharmacokinetic (PK) study in Wistar rats. Polarity-switching mode was utilized to acquire positive ion electrospray data for hesperidin and neohesperidin dihydrochalcone-d3, and negative ionization data for hesperetin and rac-hesperetin-d3. The analytes were investigated in the multiple reaction monitoring mode as the precursor/product ion pair of m/z 611.2 → 303.1 for hesperidin, m/z 616.3 → 308.3 for neohesperidin dihydrochalcone-d3, m/z 301.3 → 164.1 for hesperetin, and m/z 304.3 → 164.1 for rac-hesperetin-d3. Hesperidin and hesperetin in rat plasma were separated with solid-phase extraction using a HyperSep Retain PEP column and separated on a Hypersil GOLD Phenyl reversed-phase column using a gradient elution of 0.1{\%} formic acid in water and acetonitrile. Hesperidin was validated over the concentration range of 1-1000 ng mL-1, and hesperetin was validated over the range of 0.2-100 ng mL-1, both with r > 0.999. The respective within- and between-run precisions were 2.06-9.54{\%} and 2.11-7.76{\%}, and the within- and between-run accuracies were -6.52{\%} to 3.82{\%} and -1.62{\%} to 2.33{\%}, respectively, for both analytes. Extraction recoveries of these analytes were >87{\%}. The matrix effects were between 94.7{\%} and 113.6{\%}. All of the analytes were stable during the assay and storage in Wistar rat plasma. The lower limit of quantification of the active metabolite hesperetin is up to 200 pg mL-1, so complete plasma concentration-time profiles can be obtained by the LC-MS/MS method without the need for enzymatic hydrolysis of the serum sample.",
author = "Lee, {Jr Ting} and Pao, {Li Heng} and Hsieh, {Chang Da} and Huang, {Pei Wei} and Hu, {Oliver Yoa Pu}",
year = "2017",
month = "6",
day = "14",
doi = "10.1039/c7ay00051k",
language = "English",
volume = "9",
pages = "3329--3337",
journal = "Analytical Methods",
issn = "1759-9660",
publisher = "Royal Society of Chemistry",
number = "22",

}

TY - JOUR

T1 - Development and validation of an LC-MS/MS method for simultaneous quantification of hesperidin and hesperetin in rat plasma for pharmacokinetic studies

AU - Lee, Jr Ting

AU - Pao, Li Heng

AU - Hsieh, Chang Da

AU - Huang, Pei Wei

AU - Hu, Oliver Yoa Pu

PY - 2017/6/14

Y1 - 2017/6/14

N2 - A simple and sensitive method for the determination of hesperidin and hesperetin was necessary for a pharmacokinetic (PK) study in Wistar rats. Polarity-switching mode was utilized to acquire positive ion electrospray data for hesperidin and neohesperidin dihydrochalcone-d3, and negative ionization data for hesperetin and rac-hesperetin-d3. The analytes were investigated in the multiple reaction monitoring mode as the precursor/product ion pair of m/z 611.2 → 303.1 for hesperidin, m/z 616.3 → 308.3 for neohesperidin dihydrochalcone-d3, m/z 301.3 → 164.1 for hesperetin, and m/z 304.3 → 164.1 for rac-hesperetin-d3. Hesperidin and hesperetin in rat plasma were separated with solid-phase extraction using a HyperSep Retain PEP column and separated on a Hypersil GOLD Phenyl reversed-phase column using a gradient elution of 0.1% formic acid in water and acetonitrile. Hesperidin was validated over the concentration range of 1-1000 ng mL-1, and hesperetin was validated over the range of 0.2-100 ng mL-1, both with r > 0.999. The respective within- and between-run precisions were 2.06-9.54% and 2.11-7.76%, and the within- and between-run accuracies were -6.52% to 3.82% and -1.62% to 2.33%, respectively, for both analytes. Extraction recoveries of these analytes were >87%. The matrix effects were between 94.7% and 113.6%. All of the analytes were stable during the assay and storage in Wistar rat plasma. The lower limit of quantification of the active metabolite hesperetin is up to 200 pg mL-1, so complete plasma concentration-time profiles can be obtained by the LC-MS/MS method without the need for enzymatic hydrolysis of the serum sample.

AB - A simple and sensitive method for the determination of hesperidin and hesperetin was necessary for a pharmacokinetic (PK) study in Wistar rats. Polarity-switching mode was utilized to acquire positive ion electrospray data for hesperidin and neohesperidin dihydrochalcone-d3, and negative ionization data for hesperetin and rac-hesperetin-d3. The analytes were investigated in the multiple reaction monitoring mode as the precursor/product ion pair of m/z 611.2 → 303.1 for hesperidin, m/z 616.3 → 308.3 for neohesperidin dihydrochalcone-d3, m/z 301.3 → 164.1 for hesperetin, and m/z 304.3 → 164.1 for rac-hesperetin-d3. Hesperidin and hesperetin in rat plasma were separated with solid-phase extraction using a HyperSep Retain PEP column and separated on a Hypersil GOLD Phenyl reversed-phase column using a gradient elution of 0.1% formic acid in water and acetonitrile. Hesperidin was validated over the concentration range of 1-1000 ng mL-1, and hesperetin was validated over the range of 0.2-100 ng mL-1, both with r > 0.999. The respective within- and between-run precisions were 2.06-9.54% and 2.11-7.76%, and the within- and between-run accuracies were -6.52% to 3.82% and -1.62% to 2.33%, respectively, for both analytes. Extraction recoveries of these analytes were >87%. The matrix effects were between 94.7% and 113.6%. All of the analytes were stable during the assay and storage in Wistar rat plasma. The lower limit of quantification of the active metabolite hesperetin is up to 200 pg mL-1, so complete plasma concentration-time profiles can be obtained by the LC-MS/MS method without the need for enzymatic hydrolysis of the serum sample.

UR - http://www.scopus.com/inward/record.url?scp=85021703390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021703390&partnerID=8YFLogxK

U2 - 10.1039/c7ay00051k

DO - 10.1039/c7ay00051k

M3 - Article

AN - SCOPUS:85021703390

VL - 9

SP - 3329

EP - 3337

JO - Analytical Methods

JF - Analytical Methods

SN - 1759-9660

IS - 22

ER -